Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …

Prophylactic vaccines have been found to be highly effective in preventing infection and pre-
invasive and invasive cervical, vulvovaginal and anal disease caused by the vaccine types …

Background Cervical cancer is a major public health concern in Kenya. It is the leading
cause of cancer morbidity and mortality among women. Although screening is an effective …

Highlights•Accelerated uptake of HPV vaccination in SSA appropriately prioritised regions
with the highest incidence of cervical cancer.•High coverage achieved in HPV vaccination …

Objectives The natural history of human papillomavirus (HPV) infection has been studied
extensively in young women; this study investigated HPV infection in adult women. Methods …

Human papillomavirus (HPV) can cause several diseases, including cancers, in both sexes.
In January 2020, the Hong Kong government launched a school-based vaccination program …

Background In men, the incidence of human papillomavirus (HPV)–related cancer is rising,
but data regarding male HPV infection and seroprevalence are available from only a few …

Introduction Human papillomavirus (HPV) is the most common sexually transmitted infection.
HPV is responsible for cancer of cervix uteri. Despite its safety and immunogenicity, HPV …

Cancer survivors are at higher risk of developing HPV-associated cancers later in life, yet
their HPV vaccination rates remain lower than the general population. Improving HPV …

Background Even if vulvar cancer is not common, over one hundred women are affected in
Austria per year. There is strong evidence that basaloid and warty variants are associated …